Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-08-03
1999-07-20
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514256, 514307, 514317, 514357, 514365, 514374, 514406, 514427, 514438, 514461, 544179, 544224, 544242, 544336, 546141, 546236, 546237, 546238, 546300, 546301, 548204, 548236, 548253, 5483731, 5483751, 548482, 548560, 548561, 549 77, 549 79, 549 80, 549496, C07D20944, C07D21330, C07D21716, C07D21122, C07D30732, A61K 3144, A61K 31445, A61K 3147
Patent
active
059256311
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5393790 (1995-02-01), Reitz et al.
Black Cameron
Grimm Erich
Hughes Greg
Leger Serge
Prasit Petpiboon
Billups Richard C.
Merck & Co. , Inc.
Panzer Curtis C.
Rao Deepak R.
Rose David L.
LandOfFree
Alkylated styrenes as prodrugs to COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylated styrenes as prodrugs to COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylated styrenes as prodrugs to COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321993